First Citizens Bank & Trust’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2M | Sell |
17,404
-1,193
| -6% | -$82.3K | 0.02% | 256 |
|
|
2025
Q1 | $1.29M | Buy |
18,597
+270
| +1% | +$18.7K | 0.03% | 218 |
|
|
2024
Q4 | $1.58M | Buy |
18,327
+1,302
| +8% | +$112K | 0.03% | 201 |
|
|
2024
Q3 | $2.03M | Buy |
17,025
+1,039
| +6% | +$124K | 0.04% | 189 |
|
|
2024
Q2 | $2.28M | Buy |
15,986
+131
| +0.8% | +$18.7K | 0.04% | 178 |
|
|
2024
Q1 | $2.04M | Sell |
15,855
-1,551
| -9% | -$199K | 0.04% | 189 |
|
|
2023
Q4 | $1.8M | Buy |
17,406
+1,238
| +8% | +$128K | 0.03% | 178 |
|
|
2023
Q3 | $1.47M | Sell |
16,168
-688
| -4% | -$62.6K | 0.03% | 176 |
|
|
2023
Q2 | $1.36M | Buy |
16,856
+12,220
| +264% | +$989K | 0.03% | 183 |
|
|
2023
Q1 | $369K | Sell |
4,636
-24
| -0.5% | -$1.91K | 0.01% | 261 |
|
|
2022
Q4 | $315K | Sell |
4,660
-50
| -1% | -$3.38K | 0.01% | 264 |
|
|
2022
Q3 | $235K | Buy |
4,710
+92
| +2% | +$4.59K | 0.01% | 281 |
|
|
2022
Q2 | $257K | Buy |
+4,618
| New | +$257K | 0.01% | 318 |
|